Pharma executives selling company stock amid COVID-19 pandemic - Business Insider
6:38am PDT - October 28th, 2020 this is us - Business InsiderA Business Insider analysis found 27 biotech insiders who had cashed in more than $10 million in stock this year and two2 who made over $100 million.